Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
Doucet M, El-Turabi A, Zabel F, Hunn BHM, Bengoa-Vergniory N, Cioroch M, Ramm M, Smith AM, Gomes AC, Cabral de Miranda G, Wade-Martins R, Bachmann MF.
Doucet M, et al. Among authors: bachmann mf.
PLoS One. 2017 Aug 10;12(8):e0181844. doi: 10.1371/journal.pone.0181844. eCollection 2017.
PLoS One. 2017.
PMID: 28797124
Free PMC article.